# Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers

> **NCT01253824** · PHASE3 · COMPLETED · sponsor: **Nobelpharma** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NPC-01
- **DRUG:** IKH-01

## Key facts

- **NCT ID:** NCT01253824
- **Lead sponsor:** Nobelpharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01253824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01253824, "Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01253824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*